Thailand Radiotherapy Market Report 2022 to 2030

Thailand Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Thailand Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Thailand is dominated by a few domestic players such as Bangkok Medical Supply, OTO-Medical, and Thai Radiology Equipment. The radiotherapy market in Thailand is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Thailand Radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10THPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Thailand AUTHOR: Dr. Vishwa Modhia

Buy Now

Thailand Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Thailand Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2035, growing at a CAGR of xx% during 2022-30.

Thailand is an upper middle-income developing country located in Southeastern Asia bordering the Andaman Sea and the Gulf of Thailand. In 2020, there will be 190,636 new cancer cases in Thailand alone. According to the Global Cancer Observatory, 290,000 new cancer cases will be diagnosed by 2040.

The National Health Security Office's (NHSO) gold card universal healthcare plan helped at least 250,000 cancer patients in 2022, up from an annual average of 100,000 members in the previous five years. The gold card's cancer coverage, which includes surgery, chemotherapy, and radiotherapy, stems from the NHSO board's "Cancer Anywhere" policy, which strives to provide rapid care across the country. Thailand's government spent 4.4% of its GDP on healthcare in 2020.

thailand-radiotherapy-market-analysis

Market Dynamics

Market Growth Drivers Analysis

There are currently 35 radiation therapy facilities in Thailand, including 16 in Bangkok, 13 in the north, two in the centre, two in the south, one in the east, and one in the west. In comparison to many other countries throughout the world, healthcare in Thailand is extremely economical. As a result, it has emerged as one of the top medical tourism destinations in the globe, particularly in the Asia-Pacific area. Thailand's National Cancer Institute funds particular cancer treatments such as chemotherapy and targeted medicines. The Thai Red Cross Society also assists cancer patients who require expensive treatments. The Thai government established the National Cancer Institute of Thailand and the Universal Health Coverage Scheme to improve cancer care in Thailand. These aspects could boost Thailand's, Radiotherapy Market.

Market restraints

Radiation therapy is commonly included in cancer treatment for 50-60% of patients, although less than 10% have access in low-middle-income nations like Thailand. Patients in remote locations are up to 35% more likely to die within five years of being diagnosed with cancer. Radiation therapy is accessible in both public and private facilities in Thailand. However, more standardised, and consistent guidelines for image-guided radiation therapy (IGRT), a technique that helps ensure the accuracy and precision of radiation delivery, are required. These factors may deter new entrants into the Thailand Radiotherapy Market.

Competitive Landscape

Key Players

Thai Radiology Equipment - Thai Radiology Equipment is a leading domestic supplier of medical equipment, including radiotherapy equipment. The company offers a range of products, including linear accelerators, brachytherapy systems, and radiation protection solutions
Bangkok Medical Supply- Bangkok Medical Supply is a Thai company that provides a range of medical equipment, including radiotherapy equipment. The company has a presence in Thailand and provides equipment to several healthcare facilities
OTO-Medical- OTO-Medical is a Thai company that provides a range of medical equipment, including radiotherapy equipment. The company has a presence in Thailand and provides equipment to several healthcare facilities
Elekta - Elekta is a global company that provides advanced radiation therapy equipment and software solutions. In Thailand, the company has a strong presence and offers a range of products, including linear accelerators, brachytherapy systems, and treatment-planning software
Varian Medical Systems - Varian is a leading manufacturer of radiotherapy equipment, including linear accelerators, brachytherapy systems, and software solutions. The company has a presence in Thailand and provides equipment to several healthcare facilities

Healthcare Policies and Reimbursement Scenarios

In Thailand, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Public Health (MOPH) and the National Health Security Office (NHSO). The MOPH is responsible for regulating the use of radiation in Thailand, including the use of radiotherapy. The Thai Society of Therapeutic Radiology and Oncology (TSTRO) is the main professional organization for radiation oncologists in Thailand and works closely with the MOPH to develop guidelines and standards of practice for radiotherapy. The NHSO is responsible for reimbursing the cost of radiotherapy for eligible patients under the national health insurance program.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.